Health
Angiotensin system polymorphisms in COVID-19 | PGPM – Dove Medical Press
Polymorphisms in the ACE1, ACE2, AGT and AGTR1 genes in patients affected by COVID-19 may provide direction for personalized therapeutic strategies. Learn more.
Introduction
Over the last two decades, seven coronaviruses responsible for respiratory diseases in humans have been studied and deeply analyzed for their major lung and multi-organ damages (adverse myocardial condition, cardiomyopathy and kidney failures), including the SARS-CoV-2 responsible for COVID-19 pandemic.1–3 The clinical spectrum of SARS-CoV-2 infection varies from the most frequent asymptomatic or mild symptomatic forms to severe progressive pneumonia and death, with specific virulence…
-
Business18 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
Business17 hours ago5 things to watch on the ASX 200 on Monday 7 April 2025
-
Noosa News15 hours agoMeasles alert: Australia Zoo, Hospital ED, Sushi Hub, Holey Moley Mini Golf and train stations among QLD infection sites
-
Business14 hours ago1 ASX dividend stock down 43% I’d buy right now